Alterations in T Cell Receptor and Signal Transduction Molecules in Melanoma Patients

Clinical Cancer Research

Volumn 1, Issue 11, 1995, Pages 1327-1335

  Zea, Arnold H ^a   Curti, Brendan D ^a   Longo, Dan L ^a   Alvord, W Gregory ^b   Strobl, Susan L ^a   Mizoguchi, Hiromoto ^a   Creekmore, Stephen P ^a   O'Shea, John J ^a   Powers, Gerry C ^a   Urba, Walter J ^a   Ochoa, Augusto C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ARTICLE; BLOOD CELL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; ANIMAL; ANTIGENS, NEOPLASM; FEMALE; HUMAN; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MALE; MELANOMA; MEMBRANE PROTEINS; MICE; MIDDLE AGE; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SUPPORT, NON-U.S. GOV'T;

EID: 0028829736     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Broder, S., and Waldmann, T. A. The suppressor-cell network in cancer. N. Engl. J. Med., 299: 1281–1284, 1978.
2. Hersh, E. M., and Oppenheim, J. J. Impaired in vitro lymphocyte transformation in Hodgkin's disease. N. Engl. J. Med., 273: 1006–1012, 1965.
3. Sarzotti, M., Baron, S., and Klimpel, G. R. EL-4 metastases in spleen and bone marrow suppress the NK activity generated in these organs. Int. J. Cancer, 39: 118–125, 1987.
4. Sedlmayr, P., Rabinowich, H., Elder, E. M., Ernstoff, M. S., Kirk-wood, J. M., Herberman, R. B., and Whiteside, T. L. Depressed ability of patients with melanoma or renal cell carcinoma to generate adherent lymphokine-activated killer cells. J. Immunother., 10: 336–346, 1991.
5. Fisher, R. I., DeVita, V. T., Jr., Bostick, F., Vanhaelen, C, Howser, D. M., Hubbard, S. M., and Young, R. C. Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's disease. Ann. Intern. Med., 92: 595–599, 1980.
6. Young, R. C., Corder, M. P., Haynes, H. A., and DeVita, V. T. Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients. Am. J. Med., 52: 63–72, 1972.
7. North, R. J., and Bursuker, I. Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly–1 +2– suppressor T cells down-regulate the generation of Ly–1–2+ effector T cells. J. Exp. Med., 159: 1295–1311, 1984.
8. Watson, G. A., Fu, Y. X., and Lopez, D. M. Splenic macrophages from tumor-bearing mice co-expressing MAC-1 and MAC-2 antigens exert immunoregulatory functions via two distinct mechanisms. J. Leukocyte Biol., 49: 126–138, 1991.
9. Sondak, V. K., Wagner, P. D., Shu, S., and Chang, A. E. Suppressive effects of visceral tumor on the generation of antitumor T cells for adoptive immunotherapy. Arch. Surg., 126: 442–446, 1991.
10. Mizoguchi, H., O'Shea, J. J., Longo, D. L., Loeffler, C. M., McVicar, D. W., and Ochoa, A. C. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science (Washington DC), 258: 1795–1798, 1992.
11. Ghosh, P., Sica, A., Young, H. A., Ye, J., Franco, J. L., Wiltrout, R. H., Longo, D. L., Rice, N. R., and Komschlies, K. L. Alterations in NFkB/rel family proteins in splenic T cells from tumor-bearing mice and reversal following therapy. Cancer Res., 54: 2969–2972, 1994.
12. Finke, J. H., Zea, A. H., Stanley, J., Longo, D. L., Mizoguchi, H., Tubbs, R. R., Wiltrout, R. H., O'Shea, J. J., Kudoh, S., Klein, E., Bukowski, R. M., and Ochoa, A. C. Loss of T cell receptor ζ chain and p56lck in T cells infiltrating human renal cell carcinoma. Cancer Res., 53: 5613–5616, 1993.
13. Nakagomi, H., Petersson, M., Magnusson, I., Juhlin, C, Matsuda, M., Mellstedt, H., Taupin, J. L., Vivier, E., Anderson, P., and Kiessling, R. Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T cells and NK cells of patients with colorectal carcinoma. Cancer Res., 53: 5610–5612, 1993.
14. Balch, C. M., Houghton, A. N., and Peters, L. J. Cutaneous melanoma. In: V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles & Practice of Oncology, Ed. 4, pp. 1612–1661. Philadelphia: J. B. Lippincott Company, 1993.
15. Creekmore, S., Urba, W., Kopp, W., Ewel, C, Hecht, T., Smith, J. W., II, Janik, J., Steis, R., Fenton, R., Sharfman, W., Conlon, K., Sznol, M„ Holmlund, J., Curti, B., Gause, B., Houck, M., Beveridge, J., Jones, M., and Longo, D. Phase IB/II trial of R24 antibody and interleukin-2 (IL-2) in melanoma. Proc. Am. Soc. Clin. Oncol., 11: 345, 1992.
16. SAS User's Guide: Statistics, Version 5, Ed. 5. Cary, NC: SAS Institute, 1985.
17. Moingeon, P., Lucich, J. L., and Reinherz, E. L. Chraracterization of Fceriγ in human natural killer cells. Int. Immunol., 4: 955–958, 1992.
18. Loeffler, C. M., Smyth, M. J., Longo, D. L., Kopp, W. C., Harvey, L. K., Tribble, H. R., Tase, J. E., Urba, W. J., Leonard, A. S., Young, H. A., and Ochoa, A. C. Immunoregulation in cancer-bearing hosts: down-regulation of gene expression and cytotoxic function in CD8+ T cells. J. Immunol., 149: 949–956, 1992.
19. Walker, T. M., Yurochko, A. D., Burger, C. J., and Elgert, K. D. Cytokines and suppressor macrophages cause tumor-bearing host CD8 + T cells to suppress recognition of allogeneic and syngeneic MHC class II molecules. J. Leukocyte Biol., 52: 661–669, 1992.
20. Hellstrom, I., Warner, G. A., Hellstrom, K. E., and Sjögren, H. O. Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma. Int. J. Cancer, 11: 280–292, 1973.
21. Weiss, A., and Imboden, J. B. Cell surface molecules and early events involved in human T lymphocyte activation. Adv. Immunol., 41: 1–38, 1987.
22. Weiss, A., Koretzky, G., Schatzman, R. C., and Kadlecek, T. Functional activation of the T-cell antigen receptor induces tyrosine phosphorylation of phospholipase Cγl. Proc. Natl. Acad. Sci. USA, 88: 5484–5488, 1991.
23. Hsi, E. D., Siegel, J. N., Minami, Y., Luong, E. T., Klausner, R. D., and Samelson, L. E. T cell activation induces rapid tyrosine phosphorylation of a limited number of cellular substrates. J. Biol. Chem., 264: 10836–10842, 1989.
24. DeSilva, D. R., Urdahl, K. B., and Jenkins, M. K. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J. Immunol., 147: 3261–3267, 1991.
25. Norton, S. D., Hovinen, D. E., and Jenkins, M. K. IL-2 secretion and T cell clonal anergy are induced by distinct biochemical pathways. J. Immunol., 146: 1125–1129, 1991.
26. Quill, H., Riley, M. P., Cho, E. A., Casnellie, J. E., Reed, J. C., and Torigoe, T. Anergic Thl cells express altered levels of the protein tyrosine kinases p56, ck and p59fyn. J. Immunol., 149: 2887–2893, 1992.
27. Roth, J. A., Osborne, B. A., and Ames, R. S. Immunoregulatory factor derived from human tumors. II. Partial purification and further immunobiochemical characterization of a human sarcoma-derived immunosuppressive factor expressing HLA-DR and immunoglobulin-related determinants. J. Immunol., 130: 303–308, 1983.
28. Miescher, S., Whiteside, T. L., Carrel, S., and von Fliedner, V. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J. Immunol., 136: 1899–1907, 1986.
29. Yoshino, I., Yano, T., Murata, M., Ishida, T., Sugimachi, K., Kimura, G., and Nomoto, K. Tumor-reactive T cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor. Cancer Res., 52: 775–781, 1992.
30. Fujii, T., Igarashi, T., and Kishimoto, S. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice. J. Natl. Cancer Inst., 78: 509–517, 1987.